Chime Biologics
Thomas Matthew Risko, Vice President of Manufacturing, is fully responsible for the company’s CMC production and management, as well as engineering and expansion projects.
Thomas has over 35 years of manufacturing experience, including 25 years in the biotechnology industry, in the production of therapeutic proteins, antibodies, and vaccines in the United States. He is a manufacturing leader with experience in the production of several commercial blockbuster biologics and numerous clinical therapeutics. Previously Thomas held leadership, technical and commercial positions in Amgen Rhode Island, Regeneron Pharmaceuticals, and Bio-Rad Laboratories.
Thomas received his bachelor’s degree in Biological Sciences from the State University of New York at Albany.
This person is not in any offices